Jord BioScience Raises Series B Funding to Advance Agricultural Microbial Technologies

Jord BioScience, a science and analytics company specializing in agricultural microbial technologies, has successfully closed a Series B funding round aimed at expanding its innovative microbial solutions for crop production. The investment, led by Silver Blue LLC, includes participation from Discovery Capital Funding and other investors committed to advancing agricultural biotechnology.

The company's unique approach centers on a comprehensive microbial bank containing over 6,500 microbial isolates collected from diverse global soil ecosystems. These isolates can potentially enhance, protect, and promote crop performance across major agricultural crops including corn, soybeans, canola, and wheat.

Dr. Keri Carstens, president and CEO, emphasized the significance of the funding, highlighting the company's ability to accelerate product discovery and innovation for agricultural businesses. By leveraging its extensive microbial research, Jord BioScience aims to address critical challenges facing modern agriculture, such as increasing food production while managing environmental and financial constraints.

The investment represents a strategic opportunity to fast-track biological solutions, with the company's proprietary technology potentially reducing product development timelines from years to less than 10 months. This approach could significantly impact agricultural productivity by providing more consistent and effective microbial crop inputs.

Silver Blue LLC's director Francis Goelet noted the potential of Jord BioScience's technology to bring improved performance consistency to the biological agricultural sector, underscoring the investment's strategic importance in supporting sustainable agricultural innovation.